Silvia Johansson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Silvia Johansson has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Anders Ahnesjö
Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden
3 shared publications - Eric Grönlund
Medical radiation sciences, Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden
2 shared publications - Erik Almhagen
Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden
2 shared publications - Ingela Turesson
Dep of Immunology, Genetics and Pathology, Section for Experimental and Clinical Oncology, Uppsala University Hospital, 751 85 Uppsala, Sweden
2 shared publications - Aijun Sun
International Joint Research Center of National Animal Immunology, The College of Veterinary Medicine, Henan Agricultural University, Zhengzhou, Henan, China; Longhu Laboratory of Advanced Immunology, Zhengzhou, Henan, China; Ministry of Education Key Laboratory for Animal Pathogens and Biosafety, Henan Agricultural University, Zhengzhou, Henan, China
1 shared publication - Alexandru Dasu
The Skandion Clinic, Uppsala, Sweden; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden
1 shared publication
Latest Publications
- Open Access
- 7 November 2023
- Published by Elsevier in Physica Medica
- Vol. 115, 103157
Plan robustness and RBE influence for proton dose painting by numbers for head and neck cancers
- 7 November 2023
- Published by Elsevier in Physica Medica
- Vol. 115, 103157
Open AccessPlan robustness and RBE influence for proton dose painting by numbers for head and neck cancers
- Open Access
- 17 September 2020
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 60 (2) , 199-206
Robust treatment planning of dose painting for prostate cancer based on ADC-to-Gleason score mappings – what is the potential to increase the tumor control probability?
The aim of this study was to evaluate the potential to increase the tumor control probability (TCP) with ‘dose painting by numbers’ (DPBN) plans optimized in a treatment planning system (TPS) compa...
- 17 September 2020
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 60 (2) , 199-206
Open AccessRobust treatment planning of dose painting for prostate cancer based on ADC-to-Gleason score mappings – what is the potential to increase the tumor control probability?
The aim of this study was to evaluate the potential to increase the tumor control probability (TCP) with ‘dose painting by numbers’ (DPBN) plans optimized in a treatment planning system (TPS) compa...
- Open Access
- 1 December 2019
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 141, 164-173
High efficacy of hypofractionated proton therapy with 4 fractions of 5 Gy as a boost to 50 Gy photon therapy for localized prostate cancer
- 1 December 2019
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 141, 164-173
Open AccessHigh efficacy of hypofractionated proton therapy with 4 fractions of 5 Gy as a boost to 50 Gy photon therapy for localized prostate cancer
- Open Access
- 1 February 2019
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 131, 243
Corrigendum to “Dose painting by numbers based on retrospectively determined recurrence probabilities” [Radiother Oncol 122 (2017) 236–241]
- 1 February 2019
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 131, 243
Open AccessCorrigendum to “Dose painting by numbers based on retrospectively determined recurrence probabilities” [Radiother Oncol 122 (2017) 236–241]
- 5 December 2006
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 34 (5) , 651-657
1-[11C]-acetate PET imaging in head and neck cancer—a comparison with 18F-FDG-PET: implications for staging and radiotherapy planning
The aim of this study was to evaluate the feasibility of using 1-[11C]-acetate positron emission tomography (ACE-PET) to detect and delineate the gross tumour volume of head and neck cancer before radiotherapy, and to compare the results with those obtained using 18F-fluoro-2-deoxy-D-glucose (FDG) PET.
- 5 December 2006
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 34 (5) , 651-657
1-[11C]-acetate PET imaging in head and neck cancer—a comparison with 18F-FDG-PET: implications for staging and radiotherapy planning
The aim of this study was to evaluate the feasibility of using 1-[11C]-acetate positron emission tomography (ACE-PET) to detect and delineate the gross tumour volume of head and neck cancer before radiotherapy, and to compare the results with those obtained using 18F-fluoro-2-deoxy-D-glucose (FDG) PET.
- 1 March 2001
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 58 (3) , 287-294
Left sided vocal cord paralysis: a newly recognized late complication of mediastinal irradiation
- 1 March 2001
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 58 (3) , 287-294
Left sided vocal cord paralysis: a newly recognized late complication of mediastinal irradiation